The **norovirus** has become increasingly prevalent, affecting around **685 million** people globally every year.
Studies suggest that about **one in five** individuals of European descent carry a **mutation** in the FUT2 gene, offering them protection from the virus.
Research is ongoing to develop **vaccines**, with efforts targeting a broad immune response due to the virus's rapid evolution.
Recent advancements, such as **mRNA vaccines**, show promise, with multiple companies conducting clinical trials.
The potential success of vaccines relies on **updating** strategies to keep pace with the virus's evolving strains.
For further information, visit the original article here.